Today HealthBioAI announces the acceptance by the
@US_FDA
to proceed with clinical trial for treatment of Long Covid. See press release below: https://t.co/O49FU4TlF0 #LongCovid#CovidIsNotOver@long_covid@brucep13
In a recently published study, we have used Long COVID diagnostics with machine learning and AI on blood samples to differentiate Long COVID from Chronic Lyme Disease @brucep13#longcovid#PASC#covidlonghaulers.com https://t.co/egwQJNwpSz
Based on the @IHME_UW Institute for Health Metrics and Evaluation’s Global Burden of Disease study, #LongCovid creates a higher burden of disability per every 1,000 Americans than cancer or heart disease.
https://t.co/Oxo0DLwV4U
Join Dr. Patterson @BruceP13, CEO of @IncellDX for an in-depth webinar on using the IncellKINE Multiplex Assay developed to identify long Covid in patients. Register here: https://t.co/gvjBmbL3fb